HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design. Flyak AI, Ruiz S, Colbert MD, Luong T, Crowe JE, Bailey JR, Bjorkman PJ (2018) Cell Host Microbe 24: 703-716.e3 Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms. Mankowski MC, Kinchen VJ, Wasilewski LN, Flyak AI, Ray SC, Crowe JE, Bailey JR (2018) Proc Natl Acad Sci U S A 115: E82-E91 Hepatitis C virus NS3/NS4A DNA vaccine induces multiepitope T cell responses in rhesus macaques mimicking human immune responses [corrected]. Lang Kuhs KA, Ginsberg AA, Yan J, Wiseman RW, Khan AS, Sardesai NY, O'Connor DH, Weiner DB (2012) Mol Ther 20: 669-78 Immunotherapy for HCV infection: next steps. Lang K, Weiner DB (2008) Expert Rev Vaccines 7: 915-23
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.